Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 07, 2026 0.6843
October 06, 2026 0.6832
October 05, 2026 0.7113
October 02, 2026 0.6738
October 01, 2026 0.7027
September 30, 2026 0.6551
September 29, 2026 0.6495
September 28, 2026 0.6903
September 25, 2026 0.7116
September 24, 2026 0.7611
September 23, 2026 0.7861
September 22, 2026 0.8071
September 21, 2026 0.7843
September 18, 2026 0.7768
September 17, 2026 0.8135
September 16, 2026 0.7936
September 15, 2026 0.7996
September 14, 2026 0.8344
September 11, 2026 0.8299
September 10, 2026 0.8494
September 09, 2026 0.873
September 08, 2026 0.8599
September 04, 2026 0.852
September 03, 2026 0.8749
September 02, 2026 0.8782
Date Value
September 01, 2026 0.8835
August 31, 2026 0.846
August 28, 2026 0.9673
August 27, 2026 0.9359
August 26, 2026 0.9359
August 25, 2026 0.9509
August 24, 2026 0.9509
August 21, 2026 0.9673
August 20, 2026 0.9475
August 19, 2026 0.8917
August 18, 2026 0.8756
August 17, 2026 0.9097
August 14, 2026 0.8232
August 13, 2026 0.9681
August 12, 2026 0.9621
August 11, 2026 0.9535
August 10, 2026 0.9845
August 07, 2026 1.068
August 06, 2026 1.014
August 05, 2026 1.062
August 04, 2026 0.9845
August 03, 2026 0.9883
July 31, 2026 0.9494
July 30, 2026 0.8797
July 29, 2026 0.8984

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.589
Alnylam Pharmaceuticals, Inc. 22.16
Savara, Inc. 6.977
Vericel Corp. 5.634
Biogen, Inc. 1.741

Price to Book Value Related Metrics

PS Ratio 12.81
Price 0.1828
Earnings Yield -2.10K%
Market Cap 5.299M